Keros Therapeutics, Inc.
KROS
$14.57
$0.412.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 720.54M | 559.93M | 530.68M | 405.86M | 442.44M |
| Total Receivables | 19.37M | 4.46M | 1.92M | 1.35M | 1.78M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.62M | 1.73M | 2.38M | 2.83M | 1.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.98M | 22.77M | 17.06M | 22.68M | 17.34M |
| Total Current Assets | 759.51M | 588.89M | 552.05M | 432.71M | 463.13M |
|
|
|||||
| Total Current Assets | 759.51M | 588.89M | 552.05M | 432.71M | 463.13M |
| Net Property, Plant & Equipment | 23.14M | 23.49M | 24.19M | 18.94M | 19.43M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.91M | 3.51M | 3.04M | 3.37M | 3.26M |
| Total Assets | 784.56M | 615.89M | 579.27M | 455.02M | 485.82M |
|
|
|||||
| Total Accounts Payable | 6.64M | 4.60M | 4.98M | 6.54M | 4.99M |
| Total Accrued Expenses | 16.76M | 20.45M | 21.82M | 13.15M | 11.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.10M | 1.98M | 1.86M | 1.10M | 1.05M |
| Total Finance Division Other Current Liabilities | 13.88M | 416.00K | 354.00K | 466.00K | 855.00K |
| Total Other Current Liabilities | 13.88M | 416.00K | 354.00K | 466.00K | 855.00K |
| Total Current Liabilities | 39.38M | 27.45M | 29.01M | 21.25M | 18.72M |
|
|
|||||
| Total Current Liabilities | 39.38M | 27.45M | 29.01M | 21.25M | 18.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.31M | 16.88M | 17.43M | 12.86M | 13.15M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 55.69M | 44.33M | 46.44M | 34.11M | 31.87M |
|
|
|||||
| Common Stock & APIC | 1.15B | 1.14B | 1.06B | 890.71M | 878.49M |
| Retained Earnings | -420.33M | -568.78M | -522.75M | -469.80M | -424.54M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 728.87M | 571.55M | 532.84M | 420.92M | 453.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 728.87M | 571.55M | 532.84M | 420.92M | 453.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 728.87M | 571.55M | 532.84M | 420.92M | 453.95M |
|
|
|||||